MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.
about
MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
MYCN is a novel oncogenic targ ...... n pathway by suppressing DKK3.
@en
MYCN is a novel oncogenic targ ...... n pathway by suppressing DKK3.
@nl
type
label
MYCN is a novel oncogenic targ ...... n pathway by suppressing DKK3.
@en
MYCN is a novel oncogenic targ ...... n pathway by suppressing DKK3.
@nl
prefLabel
MYCN is a novel oncogenic targ ...... n pathway by suppressing DKK3.
@en
MYCN is a novel oncogenic targ ...... n pathway by suppressing DKK3.
@nl
P2093
P2860
P356
P1476
MYCN is a novel oncogenic targ ...... n pathway by suppressing DKK3.
@en
P2093
Leilei Lin
Linlin Zhao
Shengjin Fan
Wenjia Chen
Yanqiu Zhao
P2860
P304
P356
10.1111/JCMM.13644
P50
P577
2018-04-19T00:00:00Z